Gooch & Housego PLC ITL signs manufacturing agreement with OrganOx
March 13 2019 - 3:02AM
RNS Non-Regulatory
TIDMGHH
Gooch & Housego PLC
13 March 2019
13 March 2019
RNS REACH
Gooch & Housego PLC
("Gooch & Housego" or the "Company")
ITL signs manufacturing agreement with OrganOx
Gooch & Housego PLC (AIM: GHH), the specialist manufacturer
of optical components and systems, announces that its life science
business ITL has been awarded a five-year contract from OrganOx
Limited for the manufacture of metra, an innovative medical device
that allows livers for transplant to be stored and transported at
body temperature.
The metra system operates by supplying a donated liver with
oxygenated blood, anti-clotting drugs and assorted nutrients whilst
keeping the organ at a stable temperature (37degC). It has the
potential to significantly reduce the number of livers that are
discarded due to damage incurred by cold storage or a lack of
oxygen.
OrganOx, which was founded in 2008 as a spin-out company from
Oxford university, has already gained marketing approval for metra
in Europe and is in late stage clinical trials in the US.
Tom Cole, managing director of ITL, said: "We are delighted to
be working in partnership with OrganOx on this ground-breaking
project. This agreement is yet another important milestone
positioning metra as one of the most promising transplantation
candidates in late-stage development. This collaboration marks the
beginning of what I'm sure will be a very exciting journey for both
ITL and OrganOx."
Craig Marshall, CEO of OrganOx, said: "This agreement is
strategically important to OrganOx as we prepare to penetrate the
US market. I have a manufacturing background and I know the
importance of working with the best partners in the supply chain.
ITL is a great fit with OrganOx given their track record of
successfully bringing medical devices to the market coupled with UK
HQ with a presence in the US and in China."
University Hospitals Birmingham is one of the European liver
transplant units to have conducted clinical research into metra,
which was featured last year in the BBC TV series Surgeons: At the
Edge of Life.
Darius Mirza, professor of transplant surgery at University
Hospitals Birmingham, said: "In the 30 years I've been involved
with transplantation, there have been three or four events which
have been game changers and I'm absolutely certain we are looking
at a game changer that will change the way we practise organ
storage and transplantation."
For further information
contact: -
Gooch & Housego
Mark Webster / Andrew Boteler PLC 01460 256440
Mark Court / Sophie Wills
/ Catriona Flint Buchanan 020 7466 5000
Patrick Robb / David Anderson Investec Bank plc 020 7597 5970
Notes to editors
1. Gooch & Housego is a photonics technology business
headquartered in Ilminster, Somerset, UK with operations in the USA
and Europe. A world leader in its field, the company researches,
designs, engineers and manufactures advanced photonic systems,
components and instrumentation for applications in the Aerospace
& Defence, Industrial, Life Sciences and Scientific Research
sectors. World leading design, development and manufacturing
expertise is offered across a broad range of complementary
technologies.
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
END
NRAQLLFFKXFEBBZ
(END) Dow Jones Newswires
March 13, 2019 03:02 ET (07:02 GMT)
Gooch & Housego (LSE:GHH)
Historical Stock Chart
From Jun 2024 to Jul 2024
Gooch & Housego (LSE:GHH)
Historical Stock Chart
From Jul 2023 to Jul 2024